Ocular Therapeutix OCUL Stock Short Interest Analysis Underperforming 20260420 ROOT Root Q4 2025 earnings trounce estimates 289 revenue gain pushes shares 177 higher GH Guardant Health notches 329 Q4 2025 revenue growth yet wider than expected loss pushes stock down 089 enGene Holdings ENGN Stock Valuation Comparison Review Q1 2026 Profit Exceeds Views Grayscale Ethereum Staking ETF ETHE Positioned to Capture Ethereums Structural Upside Amid Crypto Market Rotation Is Eastern EML stock overpriced relative to performance Eastern posts 147 EPS miss amid cost pressure How Brightstar BRSL margins compare to industry leaders Eye on Rally 20260506 Forestar Group FOR drops 269 after Q1 2026 narrow EPS miss dents nearterm investor sentiment How TMobile TMUSZ differentiates itself from competitors Underperforming 20260508